Critical Path Institute Rebrands One of Its First Consortia to Highlight Focus on Alzheimer’s Disease Critical Path for Alzheimer’s Disease (CPAD) consortium’s refined, refocused mission centers on accelerating therapy developme
C-Path Appoints Dr. Amanda Klein as Executive Director for CPLD and CPA-1 Consortia TUCSON, Ariz., April 17, 2024 — Critical Path Institute (C-Path) today announced the appointment of Amanda Klein, Pharm.D., as E
C-Path’s Critical Path for Parkinson’s Names Fatta B. Nahab, MD, as Industry Co-Director TUCSON, Ariz., November 13, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Fatta B. Nahab, M.D., a